98%
921
2 minutes
20
Objective: To investigate the detection and patterns of pharyngeal reflux events in laryngopharyngeal reflux disease (LPRD) patients according to the type of ambulatory hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring (HEMII-pH) system used and assessed whether potential HEMII-pH differences impact the pretreatment to post treatment findings.
Methods: Patients with laryngopharyngeal symptoms and findings and an objective LPRD diagnosis were prospectively recruited from the European Reflux Clinic from January 2017 to December 2024. The objective diagnosis was supported by two different HEMII-pH systems (Medtronic and Sandhill). The profiles of LPRD on the objective testing devices (acid, weakly acid, and alkaline LPRD) of patients from the same clinic were prospectively compared. Reflux symptom scores (RSS) and reflux sign assessment (RSA) were used to document prepersonalized to postpersonalized treatment symptoms and findings. A study of the correlation between HEMII-pH features, symptoms, and signs was conducted.
Results: The study included gender- and age-matched 101 patients with a Sandhill HEMII-pH and 102 patients with a Medtronic HEMII-pH. Both systems detected distal esophageal reflux events similarly, but Medtronic detected significantly more pharyngeal reflux events. The Sandhill group showed higher proportions of acid and weakly acid LPRD, while Medtronic patients predominantly had alkaline reflux. Patients of both groups demonstrated significant RSS reduction after treatment (P = 0.001), with a trend toward higher response rates in the Sandhill group (P = 0.067). Symptom scores were better correlated to the Sandhill pharyngeal reflux event features than the Medtronic one.
Conclusion: The patterns of LPRD can substantially vary according to the type and catheter configuration of ambulatory HEMII-pH systems used. The differences between HEMII-pH devices support the need for revising consensus statements defining the thresholds of pharyngeal reflux events for confirming the LPRD diagnosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvoice.2025.07.003 | DOI Listing |
J Otolaryngol Head Neck Surg
July 2025
Department of Surgery, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
ImportanceProton pump inhibitors (PPIs) do not demonstrate superiority over placebo in laryngopharyngeal reflux disease (LPRD). While poorly used, many alternative medical treatments exist for controlling the gastroduodenal and gastro-pharyngeal reflux processes.ObjectiveTo investigate the clinical findings of controlled studies comparing therapeutic regimens for treating LPRD.
View Article and Find Full Text PDFOtolaryngol Head Neck Surg
July 2025
Department of Surgery, Faculty of Medicine, University of Mons (UMons), Mons, Belgium.
Objective: To investigate the clinical presentation and weaning of patients with chronic proton pump inhibitor (PPI) therapy and laryngopharyngeal reflux disease (LPRD).
Study Design: Prospective controlled study.
Methods: Patients with LPRD symptoms despite ongoing PPI therapy were prospectively recruited from two centers.
Indian J Otolaryngol Head Neck Surg
August 2025
Department of Otorhinolarngology and Head & Neck Surgery, Era's Lucknow Medical College and Hospital, Lucknow, India.
Introduction: Laryngopharyngeal reflux (LPR) is a common disease in the outpatient department of otolaryngology and is characterised by backflow of stomach contents into the pharynx and larynx resulting in significant negative impact on the quality of life of patients. The aim of study was to assess the effect of proton pump inhibitor (PPI) on quality of life in patients with LPR.
Method: 110 patients diagnosed with LPR were enrolled in study and prescribed omeprazole (20 mg) twice daily for 12 weeks.
J Voice
July 2025
Department of Surgery, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium; Department of Otolaryngology - Head and Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelin
Objective: To investigate the detection and patterns of pharyngeal reflux events in laryngopharyngeal reflux disease (LPRD) patients according to the type of ambulatory hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring (HEMII-pH) system used and assessed whether potential HEMII-pH differences impact the pretreatment to post treatment findings.
Methods: Patients with laryngopharyngeal symptoms and findings and an objective LPRD diagnosis were prospectively recruited from the European Reflux Clinic from January 2017 to December 2024. The objective diagnosis was supported by two different HEMII-pH systems (Medtronic and Sandhill).
Immunobiology
July 2025
Department of Otolaryngology, Jiangsu Provincial Second Chinese Medicine Hospital(The Second Affiliated Hospital of Nanjing University of Traditional Chinese Medicine), Nanjing 210017, Jiangsu Province, China. Electronic address:
Background: We aimed to investigate whether Liyan Kaiyin Formula (LYKYF) can relieve reflux pharyngitis in rats by regulating M1 macrophage polarization via the nuclear factor-κB (NF-κB)/Nod-like receptor protein 3 (NLRP3) pathway.
Methods: Forty rats were randomized into a sham group, a laryngopharyngeal reflux disease (LPRD) group, a LYKYF group and a LYKYF+CHPG group (n = 10). Enzyme-linked immunosorbent assay was conducted to measure the serum levels of inflammatory factors interleukin-6 (IL-6), IL-1β and tumor necrosis factor-α (TNF-α).